English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 16354/18762 (87%)
造訪人次 : 5262686      線上人數 : 60
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://ir.cnu.edu.tw/handle/310902800/31787

    標題: Mucin 2 silencing promotes colon cancer metastasis through interleukin-6 signaling
    作者: Hsu, Hui-Ping
    Lai, Ming-Derg
    Lee, Jenq-Chang
    Yen, Meng-Chi
    Weng, Tzu-Yang
    Chen, Wei-Ching
    Fang, Jung-Hua
    Chen, Yi-Ling
    貢獻者: Natl Cheng Kung Univ, Coll Med,Natl Cheng Kung Univ Hosp, Dept Surg
    Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol
    Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med
    Kaohsiung Med Univ,Kaohsiung Med Univ Hosp, Dept Emergency Med
    Natl Cheng Kung Univ, Coll Med, Lab Anim Ctr
    Chia Nan Univ Pharm & Sci, Dept Senior Citizen Serv Management
    Chia Nan Univ Pharm & Sci, Senior Citizen Dev Ctr
    關鍵字: Colorectal-Cancer
    Oligonucleotide Arrays
    Serum Levels
    日期: 2017-07-19
    上傳時間: 2018-11-30 15:56:44 (UTC+8)
    出版者: Nature Publishing Group
    摘要: Downregulation of Mucin 2 (MUC2) expression is associated with early carcinogenesis events in colon cancer. MUC2 plays a role in the progression of colon cancer, and reduced MUC2 protein expression correlates with increased interleukin-6 (IL-6) expression. However, the interaction between MUC2 and IL-6 in colorectal cancer metastasis remains unclear. We systematically analyzed MUC2 and IL-6 expression and determined the survival of cancer patients with high or low MUC2 and IL-6 expression using the Oncomine and PrognoScan databases, respectively. This analysis identified downregulation of MUC2 and overexpression of IL-6 in colon cancer but not in normal colon tissue, and this expression pattern was correlated with poor survival of colon cancer patients. We examined the effects of MUC2 on colon cancer metastasis and used vector-mediated application of short hairpin RNA (shRNA) to suppress MUC2 expression. MUC2 suppressed the migration of colon cancer cells in vitro and dramatically diminished liver metastases in vivo. Treatment with IL-6 increased signal transducer and activator of transcription 3 (STAT3) phosphorylation, promoted checkpoint kinase 2 (Chk2) activation, attenuated cAMP response element-binding protein (CREB) phosphorylation, and suppressed E-cadherin protein expression in MUC2-silenced HT-29 cancer cells. Most importantly, MUC2 is a potential prognostic indicator for colon cancer.
    關聯: Scientific Reports, v.7, pp.5823
    顯示於類別:[老人服務事業管理系] 期刊論文


    檔案 描述 大小格式瀏覽次數
    10.1038-s41598-017-04952-7.pdf10750KbAdobe PDF0檢視/開啟

    在CNU IR中所有的資料項目都受到原著作權保護.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋